Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Comment by PoorOpinionon Jun 28, 2018 4:08pm
398 Views
Post# 28247317

RE:Taimed working on a potential cure for HIV

RE:Taimed working on a potential cure for HIV
SPCEO1 wrote: WHile only in the earliest stage of discovery, Taimed has added a new potential drug it is working on to its website. It indicates it is aimed at HIV treatmetn or cure. Check it out:

 https://www.taimedbiologics.com/pipeline/37



It looks like they are considering the potential scope of the Ibalizumab antibody as a sort of 'backbone' for other therapeutic interventions against HIV. That is largely the basis of the rest of their pipeline. A reasonable thing to do but you would imagine largely speculative/theoretical at this stage.

It surprises me that if they want to be seen as a pharma leader in Taiwan that they havent made these types of early moves outside of the HIV space, say MABs/biologics in other indications. In a similar way that some here think Theratech moving beyond HIV would be benefitial.

Bullboard Posts